Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2026 Filed Oct 14, 2026 20:48 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 71 | $28.37 | $2,014.27 |
DisclosureSEC source: 0001225208-26-008409 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 783,981 Underlying: Common Stock · 71 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 30, 2026 Filed Oct 1, 2026 22:04 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 21 | $28.52 | $598.92 |
DisclosureSEC source: 0001225208-26-008044 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 783,888 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:26 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 1,613.185 | $28.67 | $46,250.01 |
DisclosureSEC source: 0001225208-26-007988 · doc4.xml · derivative · entry 1 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,739.319 Underlying: Common Stock · 1,613.185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:26 UTC |
Buckley Mortimer JDirector
|
GrantPhantom Stock Units · Derivative | 1,307.987 | $28.67 | $37,499.99 |
DisclosureSEC source: 0001225208-26-007989 · doc4.xml · derivative · entry 1 Buckley Mortimer J · CIK 0002041310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,039.756 Underlying: Common Stock · 1,307.987 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:25 UTC |
Quincey JamesDirector
|
GrantPhantom Stock Units · Derivative | 1,351.587 | $28.67 | $38,750.00 |
DisclosureSEC source: 0001225208-26-007986 · doc4.xml · derivative · entry 1 Quincey James · CIK 0001561264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,670.847 Underlying: Common Stock · 1,351.587 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:25 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 1,743.983 | $28.67 | $49,999.99 |
DisclosureSEC source: 0001225208-26-007987 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,648.823 Underlying: Common Stock · 1,743.983 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:25 UTC |
Taraporevala CyrusDirector
|
GrantPhantom Stock Units · Derivative | 1,307.987 | $28.67 | $37,499.99 |
DisclosureSEC source: 0001225208-26-007984 · doc4.xml · derivative · entry 1 Taraporevala Cyrus · CIK 0001454920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,805.658 Underlying: Common Stock · 1,307.987 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 25, 2026 Filed Sep 29, 2026 18:25 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 1,569.585 | $28.67 | $45,000.00 |
DisclosureSEC source: 0001225208-26-007985 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,210.086 Underlying: Common Stock · 1,569.585 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 19:17 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 22 | $27.55 | $606.10 |
DisclosureSEC source: 0001225208-26-007840 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 783,985 Underlying: Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2026 Filed Sep 1, 2026 21:54 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 21 | $28.46 | $597.66 |
DisclosureSEC source: 0001225208-26-007499 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 784,012 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 22:15 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 22 | $26.79 | $589.38 |
DisclosureSEC source: 0001225208-26-007145 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 785,060 Underlying: Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 12, 2026 Filed Aug 12, 2026 20:04 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
PurchaseCommon Stock | 38,000 | $26.34 | $1,000,920.00 |
DisclosureSEC source: 0001225208-26-007083 · doc4.xml · nonDerivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,173 Read SEC document |
| August 05, 2026 Filed Aug 5, 2026 20:02 UTC |
Buckley Mortimer JDirector
|
PurchaseCommon Stock | 37,632 | $25.52 | $960,368.64 |
DisclosureSEC source: 0001225208-26-006943 · doc4.xml · nonDerivative · entry 1 Buckley Mortimer J · CIK 0002041310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,632 Read SEC document |
| August 05, 2026 Filed Aug 5, 2026 20:03 UTC |
BLAYLOCK RONALD EDirector
|
PurchaseCommon Stock | 39,231 | $25.46 | $998,821.26 |
DisclosureSEC source: 0001225208-26-006944 · doc4.xml · nonDerivative · entry 1 BLAYLOCK RONALD E · CIK 0001214686 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,938 Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 15:26 UTC |
DAMICO JENNIFER B.SVP & Controller
|
SaleCommon Stock | 3,278 | $25.40 | $83,261.20 |
DisclosureSEC source: 0001225208-26-007004 · doc4.xml · nonDerivative · entry 1 DAMICO JENNIFER B. · CIK 0001805617 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,611 Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 23:50 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 24 | $25.01 | $600.24 |
DisclosureSEC source: 0001225208-26-006900 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 786,154 Underlying: Common Stock · 24 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 22:17 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 24 | $24.82 | $595.68 |
DisclosureSEC source: 0001225208-26-006638 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,901 Underlying: Common Stock · 24 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 19:43 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 84 | $24.25 | $2,037.00 |
DisclosureSEC source: 0001225208-26-006587 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,938 Underlying: Common Stock · 84 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 19:50 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 25 | $24.08 | $602.00 |
DisclosureSEC source: 0001225208-26-006273 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,979 Underlying: Common Stock · 25 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:09 UTC |
Taraporevala CyrusDirector
|
GrantPhantom Stock Units · Derivative | 1,543.845 | $24.29 | $37,500.00 |
DisclosureSEC source: 0001225208-26-006255 · doc4.xml · derivative · entry 1 Taraporevala Cyrus · CIK 0001454920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,941.287 Underlying: Common Stock · 1,543.845 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:10 UTC |
Quincey JamesDirector
|
GrantPhantom Stock Units · Derivative | 1,595.307 | $24.29 | $38,750.01 |
DisclosureSEC source: 0001225208-26-006256 · doc4.xml · derivative · entry 1 Quincey James · CIK 0001561264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,993.957 Underlying: Common Stock · 1,595.307 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:11 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 1,852.614 | $24.29 | $44,999.99 |
DisclosureSEC source: 0001225208-26-006257 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,886.001 Underlying: Common Stock · 1,852.614 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:16 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 2,058.46 | $24.29 | $49,999.99 |
DisclosureSEC source: 0001225208-26-006258 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,879.336 Underlying: Common Stock · 2,058.46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:18 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 1,904.076 | $24.29 | $46,250.01 |
DisclosureSEC source: 0001225208-26-006259 · doc4.xml · derivative · entry 1 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,631.508 Underlying: Common Stock · 1,904.076 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 19:18 UTC |
Buckley Mortimer JDirector
|
GrantPhantom Stock Units · Derivative | 1,543.845 | $24.29 | $37,500.00 |
DisclosureSEC source: 0001225208-26-006260 · doc4.xml · derivative · entry 1 Buckley Mortimer J · CIK 0002041310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,335.128 Underlying: Common Stock · 1,543.845 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:21 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 23 | $26.00 | $598.00 |
DisclosureSEC source: 0001225208-26-006072 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,772 Underlying: Common Stock · 23 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 23:58 UTC |
DAMICO JENNIFER B.SVP & Controller
|
SaleCommon Stock | 2,000 | $25.70 | $51,400.00 |
DisclosureSEC source: 0001225208-26-005911 · doc4.xml · nonDerivative · entry 1 DAMICO JENNIFER B. · CIK 0001805617 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,397 Read SEC document |
| May 29, 2026 Filed Jun 1, 2026 23:42 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 23 | $26.18 | $602.14 |
DisclosureSEC source: 0001225208-26-005687 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,789 Underlying: Common Stock · 23 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:39 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 24 | $25.33 | $607.92 |
DisclosureSEC source: 0001225208-26-005449 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773,297 Underlying: Common Stock · 24 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2026 Filed May 4, 2026 20:20 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 22 | $26.70 | $587.40 |
DisclosureSEC source: 0001225208-26-004835 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,229 Underlying: Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:22 UTC |
Taraporevala CyrusDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004650 · doc4.xml · derivative · entry 1 Taraporevala Cyrus · CIK 0001454920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,826.086 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:22 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004651 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,111.302 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:22 UTC |
Quincey JamesDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004652 · doc4.xml · derivative · entry 1 Quincey James · CIK 0001561264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,004.077 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:23 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004654 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,611.68 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:37 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004657 · doc4.xml · derivative · entry 1 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,084.684 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:37 UTC |
Desmond-Hellmann SusanDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004658 · doc4.xml · derivative · entry 1 Desmond-Hellmann Susan · CIK 0001507911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,635.605 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:37 UTC |
BLAYLOCK RONALD EDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004660 · doc4.xml · derivative · entry 1 BLAYLOCK RONALD E · CIK 0001214686 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,012.66 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:37 UTC |
Buckley Mortimer JDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004659 · doc4.xml · derivative · entry 1 Buckley Mortimer J · CIK 0002041310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,391.124 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:39 UTC |
LITTMAN DAN R.Director
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004661 · doc4.xml · derivative · entry 1 LITTMAN DAN R. · CIK 0001733004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,533.568 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:39 UTC |
NORA JOHNSON SUZANNE MDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004662 · doc4.xml · derivative · entry 1 NORA JOHNSON SUZANNE M · CIK 0001310264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,982.649 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 22:40 UTC |
Gottlieb ScottDirector
|
GrantPhantom Stock Units · Derivative | 7,686.539 | $26.67 | $205,000.00 |
DisclosureSEC source: 0001225208-26-004663 · doc4.xml · derivative · entry 1 Gottlieb Scott · CIK 0001411359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,001.814 Underlying: Common Stock · 7,686.539 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 17:16 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 22 | $27.19 | $598.18 |
DisclosureSEC source: 0001225208-26-004554 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,070 Underlying: Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:31 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 911 | $27.11 | $24,697.21 |
DisclosureSEC source: 0001225208-26-004532 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,090 Underlying: Common Stock · 911 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:52 UTC |
BOURLA ALBERTDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 21 | $28.08 | $589.68 |
DisclosureSEC source: 0001225208-26-004140 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 759,049 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:18 UTC |
Buckley Mortimer JDirector
|
GrantPhantom Stock Units · Derivative | 1,386.834 | $27.04 | $37,499.99 |
DisclosureSEC source: 0001225208-26-004084 · doc4.xml · derivative · entry 1 Buckley Mortimer J · CIK 0002041310 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,704.585 Underlying: Common Stock · 1,386.834 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:19 UTC |
Echevarria JosephDirector
|
GrantPhantom Stock Units · Derivative | 1,710.429 | $27.04 | $46,250.00 |
DisclosureSEC source: 0001225208-26-004085 · doc4.xml · derivative · entry 1 Echevarria Joseph · CIK 0001633137 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,398.145 Underlying: Common Stock · 1,710.429 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:20 UTC |
Quincey JamesDirector
|
GrantPhantom Stock Units · Derivative | 1,433.062 | $27.04 | $38,750.00 |
DisclosureSEC source: 0001225208-26-004087 · doc4.xml · derivative · entry 1 Quincey James · CIK 0001561264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,317.538 Underlying: Common Stock · 1,433.062 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:19 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 1,849.112 | $27.04 | $49,999.99 |
DisclosureSEC source: 0001225208-26-004086 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,925.141 Underlying: Common Stock · 1,849.112 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:21 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 1,664.201 | $27.04 | $45,000.00 |
DisclosureSEC source: 0001225208-26-004088 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,424.763 Underlying: Common Stock · 1,664.201 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 00:22 UTC |
Taraporevala CyrusDirector
|
GrantPhantom Stock Units · Derivative | 1,386.834 | $27.04 | $37,499.99 |
DisclosureSEC source: 0001225208-26-004089 · doc4.xml · derivative · entry 1 Taraporevala Cyrus · CIK 0001454920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,139.547 Underlying: Common Stock · 1,386.834 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.